Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Alper Sevinç,1 Metin Özkan,2 Ahmet Özet,3 Faysal Dane,4 Berna Öksüzoğlu,5 Abdurrahman Işıkdoğan,6 Feyyaz Özdemir,7 Doğan Uncu,8 Mahmut Gümüş,9 Türkkan Evrensel,10 Arzu Yaren,11 Oğuz Kara,12 Salim Başol Tekin13 1Depar...

Full description

Bibliographic Details
Main Authors: Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:OncoTargets and Therapy
Subjects:
Filgrastim
neutropenia
biosimilar
original
efficacy
Online Access:https://www.dovepress.com/biosimilar-filgrastim-vs-filgrastim-a-multicenter-nationwide-observati-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/biosimilar-filgrastim-vs-filgrastim-a-multicenter-nationwide-observati-peer-reviewed-article-OTT

Similar Items